SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.03 Cr | ₹5.62 Cr | ₹4.59 Cr | ₹4.44 Cr | ₹3.58 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUDEEP PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹6.03 Cr |
| Mar2024 | ₹5.62 Cr |
| Mar2023 | ₹4.59 Cr |
| Mar2022 | ₹4.44 Cr |
| Mar2021 | ₹3.58 Cr |
How is Deferred Tax Assets / Liabilities of SUDEEP PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.03 Cr | 7.40 | |
| Mar2024 | ₹5.62 Cr | 22.42 | |
| Mar2023 | ₹4.59 Cr | 3.26 | |
| Mar2022 | ₹4.44 Cr | 24.10 | |
| Mar2021 | ₹3.58 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,531.6 Cr | 2.6% | 29.9% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 2.6% |
29.9% |
|
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses